Serum Exosomal miRNA-125b and miRNA-451a are Potential Diagnostic Biomarker for Alzheimer’s Diseases

References

• Jia L, Fu Y, Shen L, et al. PSEN1, PSEN2, and APP mutations in 404 Chinese pedigrees with familial Alzheimer’s disease. Alzheimers Dement. 2020;16(1):178–191. doi:10.1002/alz.12005
   PubMed Web of Science ®Google Scholar
• McKeever PM, Schneider R, Taghdiri F, et al. MicroRNA expression levels are altered in the cerebrospinal fluid of patients with young-onset Alzheimer’s Disease. Mol Neurobiol. 2018;55(12):8826–8841. doi:10.1007/s12035-018-1032-x
   PubMed Web of Science ®Google Scholar
• Mckhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the national institute on aging-Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dementia. 2011;7(3):p. p. 263–269. doi:10.1002/alz.12005
   Web of Science ®Google Scholar
• Ren RJ, Qi JL, Lin SH, et al. The China Alzheimer report 2022. Gen Psych. 2022;35(1):e100751. doi:10.1136/gpsych-2022-100751
   Web of Science ®Google Scholar
• Fang LJ, Jiao B, Liu XX, et al. Specific serum autoantibodies predict the development and progression of Alzheimer’s disease with high accuracy. Brain Behav Immun. 2023;19(115):543–554. doi:10.1016/j.bbi.2023.11.018
   Google Scholar
• Cocozza F, Grisard E, Martin-Jaular L, Mathieu M, Thery C. SnapShot: Extracellular Vesicles. Cell. 2020;182(1):262–262 e261. doi:10.1016/j.cell.2020.04.054
   PubMed Web of Science ®Google Scholar
• van Niel G, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213–228. doi:10.1038/nrm.2017.125
   PubMed Web of Science ®Google Scholar
• Zappulli V, Friis KP, Fitzpatrick Z, Maguire CA, Breakefield XO. Extracellular vesicles and intercellular communication within the nervous system. J Clin Invest. 2016;126(4):1198–1207. doi:10.1172/JCI81134
   PubMed Web of Science ®Google Scholar
• Maffioletti E, Tardito D, Gennarelli M, Bocchio-Chiavetto L. Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders. Front Cell Neurosci. 2014;8:75. doi:10.3389/fncel.2014.00075
   PubMed Web of Science ®Google Scholar
• Peng Y, Croce CM. The role of MicroRNAs in human cancer. Signal Transduct Target Ther. 2016;1:15004. doi:10.1038/sigtrans.2015.4
   PubMed Web of Science ®Google Scholar
• Nagaraj S, Zoltowska KM, Laskowska-Kaszub K, Wojda U. microRNA diagnostic panel for Alzheimer’s disease and epigenetic trade-off between neurodegeneration and cancer. Ageing Res Rev. 2019;49:125–143. doi:10.1016/j.arr.2018.10.008
   PubMed Web of Science ®Google Scholar
• Zhao YZ, Bhattacharjee S, Jones BM, Hill J, Dua P, Lukiw WJ. Regulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer’s disease (AD) and in primary human neuronal-glial (HNG) cells.. Mol Neurobiol. 2014;50(1):97–106. doi:10.1007/s12035-013-8595-3
   PubMed Web of Science ®Google Scholar
• Shao Y, Dong LJ, Takahashi Y, et al. miRNA-451a regulates RPE function through promoting mitochondrial function in proliferative diabetic retinopathy. Am J Physiol Endocinol Met. 2019;316(3):E443–E452. doi:10.1152/ajpendo.00360.2018
   PubMed Web of Science ®Google Scholar
• Pearson AG, Curtis MA, Waldvogel HJ, Faull RLMDrragunow M. Activating transcription factor 2 expression in the adult human brain: association with both neurodegeneration and neurogenesis. Neuroscience. 2005;133(2):437–451. doi:10.1016/j.neuroscience.2005.02.029
   Web of Science ®Google Scholar
• Colombo M, Raposo G, Thery C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 2014;30:255–289. doi:10.1146/annurev-cellbio-101512-122326
   PubMed Web of Science ®Google Scholar
• Jack CR Jr, Bennett DA, Blennow K, et al.; Contributors. NIA-AA research framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 2018;14(4):535–562. doi:10.1016/j.jalz.2018.02.018
   PubMed Web of Science ®Google Scholar
• Kumar S, Vijayan M, Bhatti JS, Reddy PH. MicroRNAs as peripheral biomarkers in aging and age-related diseases. Prog Mol Biol Transl Sci. 2017;146:47–94.
   PubMed Web of Science ®Google Scholar
• Baudry A, Mouillet-Richard S, Schneider B, Launay JM, Kellermann O. miR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants. Science. 2010;329(5998):1537–1541. doi:10.1126/science.1193692
   PubMed Web of Science ®Google Scholar
• Bocchio-Chiavetto L, Maffioletti E, Bettinsoli P, et al. Blood microRNA changes in depressed patients during antidepressant treatment. Eur Neuropsychopharmacol. 2013;23(7):602–611. doi:10.1016/j.euroneuro.2012.06.013
   PubMed Web of Science ®Google Scholar
• Keller A, Leidinger P, Lange J, et al. Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PLoS One. 2009;4(10):e7440. doi:10.1371/journal.pone.0007440
   PubMed Web of Science ®Google Scholar
• Yuxia M, Zhennan T, Wei Z. Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosis. J Cancer Res Clin Oncol. 2012;138(12):2045–2050. doi:10.1007/s00432-012-1285-0
   PubMed Web of Science ®Google Scholar
• He HN, Liu A, Zhang W, et al. Novel plasma miRNAs as biomarkers and therapeutic targets of Alzheimer’s Disease at the prodromal stage. J Alzh Dis. 2021;83(2):779–790. doi:10.3233/JAD-210307
   Web of Science ®Google Scholar
• Cheng L, Doecke JD, Sharples RA, et al. Prognostic serum miRNA biomarkers associated with Alzheimer’s disease shows concordance with neuropsychological and neuroimaging assessment. Mol Psychiatry. 2015;20(10):1188–1196. doi:10.1038/mp.2014.127
   PubMed Web of Science ®Google Scholar
• Haqqani AS, Delaney CE, Tremblay TL, Sodja C, Sandhu JK, Stanimirovic DB. Method for isolation and molecular characterization of extracellular microvesicles released from brain endothelial cells. Fluids Barriers CNS. 2013;10(1):4. doi:10.1186/2045-8118-10-4
   PubMedGoogle Scholar
• Cheramy M, Hampe CS, Ludvigsson J, Casas R. Characteristics of in-vitro phenotypes of glutamic acid decarboxylase 65 autoantibodies in high-titre individuals. Clin Exp Immunol. 2013;171(3):247–254. doi:10.1111/cei.12026
   Web of Science ®Google Scholar
• Hong H, Li Y, Su B. Identification of circulating miR-125b as a potential biomarker of alzheimer’s disease in APP/PS1 transgenic mouse. J Alzheimers Dis. 2017;59(4):1449–1458. doi:10.3233/JAD-170156
   PubMed Web of Science ®Google Scholar
• Banzhaf-Strathmann J, Benito E, May S, et al. MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer’s disease. EMBO J. 2014;33(15):1667–1680.
   PubMed Web of Science ®Google Scholar
• Cheng C, Li W, Zhang Z, et al. MicroRNA-144 is regulated by activator protein-1 (AP-1) and decreases expression of Alzheimer disease-related a disintegrin and metalloprotease 10 (ADAM10). J Biol Chem. 2013;288(19):13748–13761. doi:10.1074/jbc.M112.381392
   PubMed Web of Science ®Google Scholar